Somatic cell nuclear transfer (SCNT) is a unique technology that produces cloned animals from single cells. It is desirable from a practical viewpoint that donor cells can be collected noninvasively and used readily for nuclear transfer. The present study was undertaken to determine whether peripheral blood cells freshly collected from living mice could be used for SCNT. We collected a drop of peripheral blood (15-45 ll) from the tail of a donor. A nucleated cell (leukocyte) suspension was prepared by lysing the red blood cells. Following SCNT using randomly selected leukocyte nuclei, cloned offspring were born at a 2.8% birth rate. Fluorescence-activated cell sorting revealed that granulocytes/monocytes and lymphocytes could be roughly distinguished by their sizes, the former being significantly larger. We then cloned putative granulocytes/monocytes and lymphocytes separately and obtained 2.1% and 1.7% birth rates, respectively (P . 0.05). Because the use of lymphocyte nuclei inevitably results in the birth of offspring with DNA rearrange-
INTRODUCTION
Cloning mammals by somatic cell nuclear transfer (SCNT) is a promising technology with potential applications in regenerative medicine, biological drug production, farming industries, and species conservation [1, 2] . Many technical and biological factors can affect the outcome of SCNT in terms of the developmental ability of cloned embryos and the health status of the offspring [3] [4] [5] . Among these factors, the donor cell type is thought to be one of the critical factors and has long been the subject of research in technical improvements to SCNT [3] [4] [5] . Thus, donor cell types have been selected for their genomic reprogrammability in terms of the efficiency of producing live clones. However, from a practical viewpoint, ease of access and noninvasiveness at cell collection and readiness for experimental use should also be key determinants of usable donor cell types. This is especially the case when invaluable animals such as the only living individual of a particular genotype is used as the donor. In this context, cells collected from a small volume of peripheral blood cells are expected to fall into this category. However, as far as we know, there have been very few reports of direct cloning from the nuclei of peripheral blood cells, although tail blood cell nuclei contributed to the indirect generation of cloned mice via chimeric mouse production using SCNT-derived embryonic stem cells [6] . Apart from peripheral blood cells, lymphocytes from lymph nodes [7] , bone marrow [8] , and liver [9] have been used successfully for producing cloned mice directly or indirectly. The present study examined the feasibility of SCNT in mice by using nuclei from peripheral leukocytes collected from living donor animals.
MATERIALS AND METHODS

Animals
B6D2F1 (C57BL/6 3 DBA/2 hybrid) female mice were purchased from Japan SLC (Shizuoka, Japan) and used as donors for oocytes, cumulus cells, and peripheral blood cells. For collecting peripheral blood cells, Oct4-green fluorescent protein (GFP) transgenic female mice (GOF18-DPE-GFP [10] ), Dppa3-Venus transgenic female mice, a 129XB6-P female mouse, and a 129XB6-F female mouse were used. The Oct4-GFP strain was derived from backcrossing the original transgenic males with B6D2F1 females for .10 generations in our laboratory and used at 8-45 weeks of age. The Dppa3-Venus strain was generated by pronuclear DNA injection into B6D2F1 3 B6 embryos in our laboratory. A male founder mouse was mated with B6 females, and transgenic females at the F 2 and F 3 generations were used as donors at 50-80 weeks of age. The 129XB6-P and 129XB6-F strains were recombinant inbred strains generated from a hybrid between 129 and C57BL/ 6 strains, and female mice at approximately 8 weeks of age were acquired from stocks at RIKEN BioResource Center. ICR female mice (CLEA Japan, Tokyo, Japan), 8-16 weeks old, were used as embryo transfer recipients. The animals were housed under controlled lighting condition (0700-2100 h) and were maintained under specific-pathogen-free conditions. All animal experiments were approved by the Animal Experimentation Committee at the RIKEN Tsukuba Institute and were performed in accordance with the committee's guiding principles. centrifugation (1200 3 g for 5 min). After centrifugation, the pellet containing leukocytes and erythrocyte debris was resuspended in Hepes-buffered potassium simplex-optimized medium (KSOM) [11] . Then, normal-looking leukocytes in the cell suspension were used as nuclear donor cells. To distinguish between lymphocytes and other cells (mostly granulocytes), the cell suspension was treated with lymphocyte-specific fluorescein isothiocyanate (FITC)-conjugated, pure Phytolacca americana-derived lectin (PWM; EY Laboratories, Inc., San Mateo, CA) and was examined using a fluorescence microscope or by fluorescence-activated cell sorting (FACS) analysis. We also tried to separate specific leukocyte types by their sizes. To determine the accuracy of such size-dependent separation, cells selected using an inverted microscope were placed on a glass slide and compressed on the surface using a CytoSpin III cytocentrifuge (Thermo Fisher Scientific Inc., Waltham, MA) at 600 rpm for 2 min. The cells were stained with May-Grünwald Giemsa stain to identify leukocyte types.
Nuclear Transfer
Nuclear transfer was carried out as described previously [12, 13] . Briefly, B6D2F1 females were superovulated by injection of 7.5 IU of equine chorionic gonadotropin and 7.5 IU of human chorionic gonadotropin (hCG) at a 46-to 52-h interval. At 14-17 h after receiving the hCG injection, the mice were euthanized, cumulus-oocyte complexes were collected from the oviducts, and cumulus cells were removed by suspending them in KSOM containing 0.1% bovine testicular hyaluronidase. Oocytes were enucleated in Hepes-buffered KSOM containing 7.5 lg/ml cytochalasin B. The donor nuclei were injected into enucleated oocytes by using a piezo-driven micropipette (Prime Tech Ltd., Ibaraki, Japan). After culture in KSOM for 1 h, injected oocytes were incubated in Ca 2þ -free KSOM containing 2.5 mM SrCl 2 , 5 lg/ml cytochalasin B, and 50 nM trichostatin A (TSA; SigmaAldrich, St. Louis, MO) under 5% CO 2 in air at 378C for 1 h. Next, the oocytes were incubated in KSOM containing 5 lg/ml cytochalasin B and 50 nM TSA for 5 h, followed by incubation in KSOM containing 50 nM TSA alone for 2 h. After being washed, the oocytes were cultured in KSOM under 5% CO 2 in air at 378C. Cloned embryos that had reached the 2-cell or 4-cell stage after 24 h or 48 h in culture, respectively, were transferred into the oviducts of pseudopregnant ICR female mice at 0.5 day postcopulation (dpc; the day following sterile mating with a vasectomized male mouse). The pregnant females were euthanized on 19.5 days postcopulation and examined for fetuses and placentas in their uteri. In the last experiment using a Dppa3-Venus female mouse, we used a gene knockout strategy with short interfering RNA (siRNA) against Xist. Reconstructed oocytes at approximately 6-7 h after activation were injected with siRNA (25 lM) against Xist using a piezodriven micropipette, as described previously [14] .
Fluorescence-Activated Cell Sorting
After red blood cells were lysed, peripheral blood cells were stained with FITC-conjugated PWM lectin and phycoerythrin-conjugated anti-Mac-1, antiGr-1, anti-B220, anti-CD4, or anti-CD8 antibody (eBioscience, San Diego, CA). The stained cells were analyzed and sorted using a FACSAria instrument (BD Biosciences, San Jose, CA).
Analysis of Rearranged Immunoglobulin Variable Region Genes
Recombination of the immunoglobulin heavy chain region was detected as described by Rohatgi et al. [15] with slight modifications as follows. The first PCR amplification was carried out using a Multiplex PCR kit (TaKaRa Bio Inc., Kyoto, Japan) with a mixture of the ''external'' VH primers (either of two sets for VH1-VH7 and VH8-VH16) and the ''external'' JH primer as described [15] . To obtain clear results, we next performed nested PCR with a mixture of the ''internal'' VH primers and the ''internal'' JH primers under the same PCR conditions as described for the first PCR. The PCR products were analyzed using 2% agarose gel electrophoresis.
Statistical Analysis
Developmental rates of embryos were analyzed using the chi-square test with Yates correction. The size of each type of leukocyte was analyzed by oneway analysis of variance, followed by the Tukey-Kramer procedure for multiple comparisons. A P value of ,0.05 was considered statistically significant.
RESULTS
In a preliminary experiment, we tested how much peripheral blood was needed for preparing donor cells for SCNT. Different amounts of peripheral blood were collected from the tail through an incision made by a blade (Fig. 1A) . After lysing the red blood cells (Fig. 1B) and washing by centrifugation, we placed the remaining cells (mostly leukocytes) in a 3-to 4-ll drop of 10% polyvinylpyrrolidone in Hepes-buffered KSOM, according to our routine SCNT protocol. For efficient pickup of donor cells using an injection pipette, at least 5-10 donor cells needed to be observed in the visual field at 2003 magnification (the combination of a 203 objective lens and a 103 eyepiece). We finally determined that cells from an initial blood volume of approximately 10-15 ll were sufficient for SCNT. Therefore, in subsequent experiments, we collected approximately 30-45 ll of blood from healthy adult mice and a smaller drop (approximately 15-20 ll) from aged or small animals.
We first performed SCNT experiments by using donor cells selected randomly from a suspension of peripheral leukocytes collected from B6D2F1 female mice. At 24 h after oocyte activation, 51% and 65% of the embryos that survived nuclear transfer developed to the 2-cell stage in 5 nM TSA and 50 nM TSA groups, respectively. These rates were significantly lower than the 2-cell development rate of cumulus cell-derived embryos (Table 1) . This difference was caused mainly by the high incidence of fragmentation of leukocyte-derived embryos before the first cleavage. After the transfer of 2-cell embryos into recipient females, 3.6% and 2.0% of them developed into offspring at term following treatment with 5 and 50 nM TSA, respectively (Table 1) . Although these birthrates were significantly lower than those of cumulus cell-derived cloned embryos, our data indicated that peripheral leukocytes could indeed be used as donor cells for producing living cloned mice. Two leukocyte nucleus-derived clones that were nursed by a foster mother grew into fertile adults and lived until 14 months and .16 months, respectively (Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod. org).
We sought to find a method with which to select leukocytes other than lymphocytes for SCNT, because mice born from lymphocyte nuclei would have rearranged DNA sequences [7, 9] and thus would not be suitable donor animals from which to make clones. First, we examined whether lymphocytes could be identified by FITC-conjugated PWM lectin, which reportedly has specificity to such cells. As expected, only some of the peripheral leukocytes were positively stained with PWM (Fig.  1C) . However, FACS analysis using specific antibodies revealed that T cells but not B cells could be identified by PWM lectin (Supplemental Fig. S2 ).
We then examined whether cell size could be used for identifying particular types of leukocytes. We prepared suspensions of granulocytes, monocytes, B cells, helper T cells (CD4þ), and killer T cells (CD8þ) by FACS analysis and measured their sizes by microscopy. As shown in Figure 1D , monocytes and granulocytes were significantly larger than lymphocytes (P , 0.05). As far as we observed, mouse peripheral leukocytes were divided roughly into two populations, larger than ;8 lm in diameter and smaller than ;6 lm, which were easily identified using differential interference contrast optics (Fig. 1C) . Based on these results, we used cell populations with a diameter of .8 lm as putative granulocytes/monocytes in subsequent SCNT experiments. When these larger cells were selected and stained with MayGrünwald Giemsa stain, the majority (85%, 84 of 99) of cells KAMIMURA ET AL.
were identified as granulocytes or monocytes (Fig. 1E) . As monocytes were apparently less frequent than granulocytes (approximately 1:4 ratio [ Fig. 1E]) , ''granulocyte/monocyte cloning'' will be referred to simply as ''granulocyte cloning'' hereafter. When smaller cells were picked and stained, 91% (32 of 35) were identified as lymphocytes with a round nucleus and a high nucleocytoplasmic ratio (data not shown).
In the next series of experiments, we undertook SCNT using nuclei from putative granulocytes and lymphocytes to compare the developmental potential of their resultant cloned embryos. At 24 h, granulocyte-derived cloned embryos showed a lower 2-cell formation rate than lymphocyte-derived embryos because of the high incidence of fragmentation (22.6% vs. 9.2%; P , 1 3 10 À6 ) ( Table 2 ). There was no statistically Monocytes and granulocytes were significantly larger than lymphocytes. E) Putative granulocytes were selected for SCNT, using an inverted microscope, based on their larger sizes. After they were settled on the surface of the slide glass by centrifugation, they were stained with May-Grü nwald Giemsa stain. Therefore, the cells in this figure are larger than those in B and C. Most cells in the image are granulocytes with a lobular nucleus, but two show the typical features of lymphocytes with a round nucleus and a high nucleocytoplasmic ratio (arrows). A large monocyte-like cell is also seen in this figure (arrowhead). Bar ¼ 10 lm.
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significant difference between lymphocyte-derived embryos and cumulus cell-derived embryos in fragmentation rate. To determine the genomic reprogrammability of these donor cell types, we cultured embryos for a further 48 h and observed the rate of development to the 4-cell stage. The 4-cell formation rate was significantly higher in the granulocyte-derived embryos than in the lymphocyte-derived embryos (77.7% vs. 67.5%, respectively; P , 0.005) ( Table 2 ). Among the three experimental groups, cumulus cell-derived embryos showed the best 4-cell formation rate (89.1%) ( Table 2 ). After we performed embryo transfer, there was no significant difference in the birth rate between the granulocyte and lymphocyte clone groups ( Table 2 ). After pups were recovered, three from each group were fostered by lactating mothers. Two of the granulocyte-derived clones grew into normal-looking adults and gave birth to normal litters when mated with adult males. All the lymphocyte-derived clones died before weaning (21 days) from unknown causes. These three offspring were confirmed to be derived from B cells by detecting recombination of the immunoglobulin heavy chain region (Supplemental Fig. S3 ).
As shown above, the genomes of at least some of the granulocytes, which had been putatively selected based on size, gave rise to normal-looking offspring that grew into fertile adults. We then applied this granulocyte SCNT technique to propagate four mouse strains. The first, the Oct4-GFP strain [10] , was successfully cloned to produce female offspring at a birth rate of 1.2% (Table 3 ). The second strain was Dppa3-Venus. This strain was originally generated in our laboratory but accidentally only two aged infertile females remained alive. Therefore, SCNT was the last means with which to conserve this strain. The first two SCNT experiments failed to produce term offspring, but one healthy pup and one stillborn pup were born at the third trial using Xist-siRNA treatment ( Table 3) .
The third and fourth strains were 129XB6-P and 129XB6-F, respectively, derived from a set of recombinant inbred strains between C57BL/6 and 129 strains. Initially, we attempted to generate cloned mice from cumulus cells of 129XB6-P and 129XB6-F female mice for a different project, but the donor females failed to ovulate on the day of the SCNT experiment.
We immediately shifted to granulocyte cloning by collecting blood cells from the carcasses. After transfer of the reconstructed embryos, we obtained one cloned offspring from each strain. As shown in Table 3 , there was no significant difference in each developmental parameter among the four strains used, although their genetic backgrounds differed.
Finally, we performed a detailed morphological observation of granulocyte-derived embryos at different timings after activation with the aim of detecting the probable cause of frequent fragmentation before the first mitosis. The possible causes might have been incomplete breakdown of the donor plasma membrane at nuclear transfer [16] or some harmful effect of the granulocyte secretory vesicles to the recipient oocytes. One or two granulocytes were injected into enucleated oocytes and then observed at 4, 8, and 17 h after oocyte activation. Oocytes injected with two granulocytes showed a better (pseudo)pronuclear formation rate and a lower fragmentation rate than those injected with one granulocyte (Supplemental Table S1 ). This result indicated that the fragmentation of granulocyte-derived embryos was most likely caused by incomplete breakdown of the donor plasma membrane at nuclear transfer rather than the harmful effect of the granulocyte secretory vesicles (see Discussion).
DISCUSSION
In this study, we used mouse as the model for the study of SCNT, using peripheral blood cells. Mouse cloning is different from cloning in farm animals or other large animals in terms of the protocols for preparing donor cells. In typical SCNT in large animals, donor cells such as fibroblasts or epithelial cells from biopsy samples are proliferated in vitro and then cultured under serum-starved or confluent conditions to induce them to enter the G0/G1 phase of the cell cycle, which is a prerequisite for synchrony with the recipient ooplasm [17] . In mice, by contrast, donor cells such as cumulus cells [12] or immature Sertoli cells [18] , which are predominantly at the G0/G1 stage by nature, are collected fresh from donor animals and used immediately for SCNT. This arises at least in part from the unique character of mouse cells, which are prone to genetic and * All donor cells were collected fresh from B6D2F1 females. All cloned embryos were treated with 50 nM trichostatin A (TSA). z Values with different superscripts within the same column are significantly different (P , 0.05; chi-squared test with Yates correction).
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epigenetic aberrations under in vitro proliferation conditions compared with cultured cells from other species [19] . Therefore, it is very common that one or more donor mice need to be euthanized in each SCNT experiment. In this respect, our cloning procedure using peripheral blood cells is unique and can be used for generating clones without sacrificing the donor animals. We also expect that donor cells could be collected repeatedly from one animal. Indeed, in the experiments using the Dppa3-Venus strain, the third trial gave rise to the first cloned offspring.
In recent years, the number of genetically modified mouse strains has been increasing rapidly, and this necessitates a demand for the ''rescue'' of strains with accidental or genetically caused infertility. Currently, one of the major strategies for the conservation of mouse genetic resources has been intracytoplasmic sperm injection (ICSI). ICSI in the mouse is a very reliable technique for fertilizing an oocyte by using a single spermatozoon or even an immature one (e.g., a spermatid) [20, 21] . Therefore, it is very probable that only one founder or a ''last-of-line'' male mouse could be used successfully for ICSI to propagate a valuable strain. Even males at 36 months of age can be used for producing offspring by round spermatid injection [22] . However, ICSI can be applied in practice only when the donor animals are male and they have haploid male germ cells in their testes. Conception with primary or secondary spermatocytes is also possible, but these younger spermatogenic cells need additional micromanipulation steps for constructing diploid embryos [23, 24] . Conversely, when male donors have no haploid germ cells or only female donors are available, SCNT rather than ICSI may offer a better chance for rescuing their genotype. Furthermore, SCNT is also advantageous over ICSI in animal strains needing conservation but carrying multiple mutant genes or those with an undefined genetic background. Although the reprogrammability of peripheral leukocytes seemed lower than that of other standard donor cells including cumulus cells, this technical difficulty might be overcome by future technical improvements, as previously achieved with treatment with histone deacetylase inhibitors, knockdown by siRNA interference against Xist, or their combination [13, 14] . Knockdown against Xist was very effective for cloning male, but not female, mice as we reported [14, 25] . In the present study, it was intriguing that Dppa3-Venus female clones were first obtained when Xist knockdown was employed. It is probable that the use of a higher concentration of siRNA against Xist (25 lM) than usual (5 lM) might have resulted in the birth of female clones, but this possibility needs further study.
One of the important points of cloning mice using peripheral blood cells is avoiding the use of lymphocytes as donors, because cloning from such nuclei would inevitably generate mice with DNA rearrangements [7, 9] . The most reliable method for sorting out lymphocytes from cell suspensions should be FACS, but this needs large cell numbers. Therefore, in this study, we examined the feasibility of selecting cells by their sizes, based on data for each cell type obtained by FACS (Fig. 1D) . Because granulocytes and monocytes are significantly larger than other cell types, we could select them from the leukocyte suspension at approximately 85% accuracy; thus minimizing the possibility of selecting lymphocytes. As this is a very simple technique, we expect that it could be reproduced easily in other laboratories after practice. There was a clear technical disadvantage to cloning granulocytes because approximately 20% of the reconstructed embryos underwent fragmentation before the first cleavage (Tables 2 and 3 ). This is approximately twofold higher than that of lymphocyte cloning and fivefold higher than that of cumulus cell cloning. Fragmentation of reconstructed cloned embryos is mostly caused by the disorganization of microtubule organizing centers in activated oocytes, which might occur in association with delayed or incomplete intermingling of the donor nucleus with the cytoplasm [16] . This seemed to be the case with granulocyte cloning because the rate of fragmentation was significantly decreased when two granulocytes were injected into single enucleated oocytes (Supplemental Table S1 ). It is possible that the plasma membrane of granulocytes is more resilient than that of other donor cell types. Another possibility was the harmful effect of enzymes released from the granulocyte secretory vesicles. It is known that the acrosomal enzyme contents from multiple spermatozoa used for ICSI causes deformation of the injected mouse oocyte [26] . Our experiment suggested that the cell toxicity of granulocyte vesicles was an unlikely cause of fragmentation in granulocyte clones because injection with two granulocytes did not increase, but rather decreased, the fragmentation rate.
In conclusion, the present study has demonstrated for the first time that mice could be cloned using the nuclei of peripheral blood cells. These cells could be used for cloning immediately after collection and no donor animals need to be euthanized. This technique would be applicable for generating genetic copies of invaluable strains of mice, which cannot be preserved by other assisted reproduction techniques such as conventional in vitro fertilization or ICSI.
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